Anti-IL-5 biologics and rheumatoid arthritis: a single-centre 500 patient year exposure analysis

Dean, N.J. orcid.org/0000-0002-0627-7081, Clifton, I.J., Salman, R. et al. (4 more authors) (2024) Anti-IL-5 biologics and rheumatoid arthritis: a single-centre 500 patient year exposure analysis. RMD Open, 9 (4). e003583. ISSN 2056-5933

Abstract

Metadata

Item Type: Article
Authors/Creators:
Copyright, Publisher and Additional Information:

© Author(s) (or their employer(s)) 2023. This is an open access article under the terms of the Creative Commons Attribution License (CC-BY 4.0), which permits unrestricted use, distribution and reproduction in any medium, provided the original work is properly cited.

Keywords: Arthritis; Arthritis, Rheumatoid; Biological Therapy; Immune System Diseases
Dates:
  • Published: 14 February 2024
  • Published (online): 19 December 2023
  • Accepted: 23 November 2023
Institution: The University of Leeds
Academic Units: The University of Leeds > Faculty of Medicine and Health (Leeds) > School of Medicine (Leeds) > Institute of Rheumatology & Musculoskeletal Medicine (LIRMM) (Leeds)
Depositing User: Symplectic Publications
Date Deposited: 12 Jun 2024 10:11
Last Modified: 12 Jun 2024 10:11
Status: Published
Publisher: BMJ
Identification Number: 10.1136/rmdopen-2023-003583
Related URLs:
Open Archives Initiative ID (OAI ID):

Export

Statistics